CareDx's (CDNA) "Neutral" Rating Reaffirmed at HC Wainwright

HC Wainwright reaffirmed their neutral rating on shares of CareDx (NASDAQ:CDNA – Free Report) in a report published on Friday, Benzinga reports. CDNA has been the topic of a number of other reports. StockNews.com cut CareDx from a buy rating to a hold rating in a research note on Wednesday. Raymond James downgraded CareDx from […]

Related Keywords

United States , Raymond James , Craig Hallum , Quest Partners , Caredx Company Profile , Goldman Sachs Group , Cetera Trust Company , Caredx Inc , Nisa Investment Advisors , Headlands Technologies , Free Report , Moderate Buy , Get Free Report , Investment Advisors , Allosure Kidney , Allomap Heart , Allosure Heart , Allosure Lung , Caredx Daily ,